CLINICAL_TRIALS
withdrawal
· 2013-05-03
Clinical Trial Update: Ranibizumab as a Rescue Therapy for Diabetic Macular Edema [Phase 2]
Summary
The Phase 2 trial of ranibizumab as rescue therapy for diabetic macular edema has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: New England Retina Associates | Conditions: Diabetic Macular Edema | Phase 2 | Status: WITHDRAWN